(c) 2024 PillSync.com

Cephalexin 500 MG Oral Capsule

INDICATIONS AND USAGE Cephalexin Capsules, USP is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes (Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin Capsules, USP is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of Cephalexin Capsules, USP in the subsequent prevention of rheumatic fever are not available at present.) Otitis media due to Streptococcus pneumoniae, Haemophilus influenzae , Staphyloccus aureus, Streptococcus pyogenes, and Moraxella catarrhalis Skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes Bone infections caused by Staphylococcus aureus and/or Proteus mirabilis Genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis , and Klebsiella pneumoniae Note –Culture and susceptibility tests should be initiated prior to and during therapy. Renal function studies should be performed when indicated. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cephalexin and other antibacterial drugs, Cephalexin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

remedyrepack inc.


4 years ago CAPSULE GREEN J2 J2 Cephalexin 500 MG Oral Capsule

CAPSULE GREEN J2 J2

HOW SUPPLIED Cephalexin capsules, USP are available in: The 250 mg capsules are a white to off-white powder filled into size 2 capsules (white opaque and dark green opaque) that are imprinted with identity code “J1” on the dark green opaque cap, and “J1” on the white opaque body in edible black ink. The 500 mg capsules are a white to off-white powder filled into size 0 capsules (light green opaque and dark green opaque) that are imprinted with identity code "J2” on the dark green opaque cap, and “J2” on the light green opaque body in edible black ink. They are supplied by Altura Pharmaceuticals, Inc. as follows: NDC Strength Quantity/Form Color Source Prod. Code 63874-111-14 250 mg 14 capsules in a Plastic Bottle green 0143-9898 63874-111-28 250 mg 28 capsules in a Plastic Bottle green 0143-9898 63874-111-30 250 mg 30 capsules in a Plastic Bottle green 0143-9898 63874-111-40 250 mg 40 capsules in a Plastic Bottle green 0143-9898 63874-111-01 250 mg 100 capsules in a Plastic Bottle green 0143-9898 63874-112-14 500 mg 14 capsules in a Plastic Bottle dark green 0143-9897 63874-112-28 500 mg 28 capsules in a Plastic Bottle dark green 0143-9897 63874-112-30 500 mg 30 capsules in a Plastic Bottle dark green 0143-9897 63874-112-40 500 mg 40 capsules in a Plastic Bottle dark green 0143-9897 63874-112-01 500 mg 100 capsules in a Plastic Bottle dark green 0143-9897 Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light resistant container with a child resistant closure.


More pills like CAPSULE J2 J2












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site